Latest News

COVID-19 Updates

COVID-19 Information for the Public, MIRTPs and Others

As Nova Scotia’s MIRTP regulator, our mandate is to protect the public by supporting MIRTPs to provide safe, competent, ethical and compassionate care. We recognize the impact of the COVID-19 outbreak and we are taking steps to maintain the health and safety of our staff, guests and the public. 

The NSCMIRTP's aligns office restrictions with the Nova Scotia Public Health COVID-19 restrictions. Staff are currently working a hybrid model of 50% office and 50% virtually and are available by email and phone. To meet in person please arrange an appointment in advance. Stakeholders should not experience any disruption in service. Please email or call 902-832-3167 to contact a member of staff.

Immunizations have a significant and positive impact on the health of our population. Widespread vaccination shortens the duration of disease outbreaks, maintains public safety, reduces the burden on the health care system and keeps health care providers safe to care for clients in need. The NSCMIRTP recommends that MIRTPs be vaccinated against COVID-19 and encourages MIRTPs to use current science-based sources and their knowledge, and ethical frameworks as the foundation for their decision. NSCMIRTP also recommends that any decision to require MIRTPs to be vaccinated should be made by MIRTPs and employers in consideration of the practice context.

Scroll down this page for information and tools to support you during the pandemic:

As part of our collaborative efforts, we have been sharing information from our provincial and federal government partners related to the COVID-19 vaccine and other pandemic information. However, please be aware that NSCMIRTP is not responsible for matters related to vaccine certification, education, hiring/employment, or non-regulatory communications. If you have any questions about the COVID vaccine program, please reach out to the Department of Health & Wellness at If you have any questions about licensing, professional practice, or any other area of our mandate, please let us know.

We continue to operate within our mandate to issue licenses to qualified MIRTPs in Nova Scotia, set the practice standards, support MIRTPs to uphold the standards, approve MIRTP education programs, enhance the continuing competence of MIRTPs, and address complaints received about MIRTP practice.  

For the most current information on the virus, visit:

  1. Government of Nova Scotia News Release

  2. Government of Nova Scotia on COVID-19 

  3. Government of Canada on COVID-19  

  4. PHAC Guidelines for Workplaces and Businesses During COVID-19 Pandemic

  5. PHAC Recommendations for those vaccinated with vaccines not authorized by Health Canada for those staying in Canada to live, work or study

  6. NACI Recommendations on the use of COVID-19 vaccines and Summary of the updated vaccine statement

  7. NACI Rapid Response: Interchangeability of authorized COVID-19 vaccines and Summary of the rapid response.

  8. NSHEALTH Updates

    1. Vaccine information

  9. NSHEALTH COVID-19 Research and Learning Opportunities

    Includes  recommendations for health care providers based on constantly changing ongoing research 

  10. COVID-19 Testing

    Everyone should get tested regularly for COVID-19. Even if you have no symptoms or only mild symptoms, you should get tested.

    Book an appointment for a standard test at a primary assessment centre. Rapid testing is available without appointment at pop-up sites for people who are 16 or older and have no symptoms.

    Visit the Nova Scotia Health Authority website for more information about testing. Please do not call 811 for general information about testing. Only call 811 if you can’t book a test online.
    Please review the current possible exposure notices and follow the public health direction if a notice applies to you.

  11. The Public Health Agency of Canada (PHAC) Webinar for Health Care Providers Presents : COVID-19 Variants and Vaccines

    The Public Health Agency of Canada COVID-19 vaccine webinars can be found at:

    @ the National Collaboration Centre for Infectious Diseases :

    @ CANVax:

  12. Please find attached the following updated document, Nova Scotia COVID-19 Vaccine Program – Information for Health Care Professionals – November 29, 2021. 

    This evergreen document is also available at: (Immunization tab).

     New information/notable updates include:

    • Document *updates* throughout to include information related to Pfizer Comirnaty COVID-19 vaccine (10 mcg) in children 5 – 11 years of age

    • Booster doses of COVID-19 vaccine (question 4) *update*

    • Safety in adolescents and children (question 9) *update*

    • Resources for health care providers, parents and caregivers to create a positive immunization experience (question 11) *update*

    • Vaccine-induced Immune Thrombotic Thrombocytopenia information related to Janssen COVID-19 vaccine (question 14) *update*

    • Capillary Leak Syndrome information related to Janssen COVID-19 vaccine (question 16) *update*

    • Table 3: mRNA COVID-19 Vaccines authorized for use in Canada *update*

    • Table 4: Pfizer BioNTech Comirnaty Summary of Use *new*

    • Table 5: Moderna Spikevax Summary of Use *new*

    • Table 6: Viral vector COVID-19 vaccines available for use in Canada *new*

    • Minimum intervals of COVID-19 vaccines (question 23) *update*

    • Concomitant administration of COVID-19 vaccines with other vaccines (question 27) *update*

    • COVID-19 vaccines received out of Canada (question 39) *update*

    • Allergen information related to Janssen COVID-19 vaccine (question 41) *update*

    ​The Moderna Spikevax/Pfizer BioNtech Comirnaty COVID-19 Vaccine Consent Form(for downtime procedures) is available here:

    The COVID-19 Vaccine Booster Dose Information Sheet is available here:

    The Pediatric 5 to 11 Years Old – Pfizer BioNTech Comirnaty COVID-19 Vaccine Consent Form (for downtime procedures) is available here:

    The Pediatric Vaccine Information and Aftercare Sheet is available here:


Date Posted: December 3, 2021